col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: Thomson Reuters (Prous Science)
  original article Journal Date Title Authors All Authors
1 [GO] Drugs of the Future 2021―Dec―13 Molnupiravir. RNA-directed RNA polymerase (RdRp) inhibitor, Treatment of mild to moderate COVID-19 G. Kaul, A. Dasgupta, S. Chopra
2 [GO] Drugs of the Future 2021―Oct―22 Repurposing approach of fluvoxamine for COVID-19 M.W. McCarthy
3 [GO] Drugs of the Future 2021―Sep―22 Investigational antiviral drugs for the treatment of COVID-19 C.T.R. Vegivinti, M. Assi, R. Talwani, V. Koblizek, K. Burke, Z. Temesgen
4 [GO] Drugs of the Future 2021―Sep―22 Investigational immunomodulatory therapies for COVID-19 M. Assi, K.M. Koshy, W. El Atrouni, K. Burke, M. Berg, A. Opardija, Z. Temesgen
5 [GO] Drugs of Today 2021―Apr―07 New product intros [Ad5-nCoV, COVID-19 inactivated vaccine (WIV04 strain), Ebola virus vaccine (rVSV-EBOV, live), JNJ-78436735, lonafarnib, margetuximab, romiplostim (new indication), tenapanor (first-in-class), tirbanibulin, tocilizumab (new indication), trilaciclib hydrochloride, ZF-2001] A. Babu
6 [GO] Drugs of Today 2021―Mar―05 New product intros [berotralstat hydrochloride, cetuximab sarotalocan, daratumumab sc (new indication), eptacog beta, coagulation factor VIIa-jncw, etesevimab, evinacumab-dgnb (first-in-class), human SARS-CoV-2 inactivated vaccine, inclisiran, orelabrutinib, relugolix (new indication), remogliflozin etabonate/vildagliptin (new combination), surufatinib, voclosporin]
7 [GO] Drugs of Today 2021―Feb―15 New product intros [anakinra (new indication), bamlanivimab, baricitinib (new indication), BBIBP-CorV, belimumab (new indication), calcium oxybate/magnesium oxybate/potassium oxybate/sodium oxybate (new formulation), casirivimab/imdevimab, ensartinib hydrochloride, favipiravir (new indication), Gam-COVID-Vac, inactivated SARS-CoV-2 vaccine, loteprednol etabonate (new indication), lumasiran (first-in-class), mRNA-1273, rilonacept (new indication), tozinameran]
8 [GO] Drugs of the Future 2020―Jun―08 Remdesivir. RNA-dependent RNA polymerase inhibitor, Treatment of Ebola virus infection, Treatment of SARS-CoV-2 infection (COVID-19)
9 [GO] Drugs of the Future 2020―May―05 Taking aim at a fast-moving target: targets to watch for SARS-CoV-2 and COVID-19 L. Sorbera, A. Graul, C. Dulsat


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.010 sec